Analysis of information sources in references of the Wikipedia article "Marion Merrell Dow" in English language version.
Sanofi-Aventis is closing its Kansas City manufacturing plant after failing to find a satisfactory buyer for the operation, which employs 370 people. The decision to shutter the 33-year-old plant, which manufactures solid-dose oral medications including Allegra, marks the end of an era. It was the last to have been operated by Marion Laboratories, the pharmaceutical empire established by Ewing Kauffman. Aventis, later Sanofi-Aventis, has owned it since 2000. "There were a number of criteria involved in deciding to close, but ultimately, it was a lack of growth in demand for the products made in Kansas City," said Jack Cox, a spokesman for the French firm.
These are the names and the order of the ownership since Ewing Kauffman's business interests were dispersed following his death: Marion Laboratories became Marion Merrill Dow, which was sold to Hoechst Marion Roussel and finally, the present arrangement. Cerner Corporation, with world headquarters in North Kansas City, Mo., is purchasing this campus to keep up with its rapid growth to serve an international list of clientele. Aventis will abandon the campus by the end of 2006, following its worldwide reorganization.
{{cite web}}
: CS1 maint: unfit URL (link)Sanofi-Aventis is closing its Kansas City manufacturing plant after failing to find a satisfactory buyer for the operation, which employs 370 people. The decision to shutter the 33-year-old plant, which manufactures solid-dose oral medications including Allegra, marks the end of an era. It was the last to have been operated by Marion Laboratories, the pharmaceutical empire established by Ewing Kauffman. Aventis, later Sanofi-Aventis, has owned it since 2000. "There were a number of criteria involved in deciding to close, but ultimately, it was a lack of growth in demand for the products made in Kansas City," said Jack Cox, a spokesman for the French firm.